Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Didier Ferriby"'
Autor:
Arnaud Kwiatkowski, François Sellal, Laurent Kremer, Didier Ferriby, Jérôme De Seze, Thibaut Fabacher, Sylvie Courtois, Nicolas Collongues, Hélène Zéphir, Olivier Outteryck, Jean-Claude Ongagna, Patrick Vermersch, Kévin Bigaut
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, SAGE Publications, 2021, 27 (5), pp.729-741. ⟨10.1177/1352458520936239⟩
Multiple Sclerosis Journal, SAGE Publications, 2021, 27 (5), pp.729-741. ⟨10.1177/1352458520936239⟩
Background: Data are needed on long-term effect of natalizumab (NTZ) in relapsing-remitting multiple sclerosis (RRMS). Objectives: To evaluate the time of onset of secondary progressive phase in patients with an RRMS treated with NTZ and to investiga
Autor:
Christel Depienne, Sabine Defoort-Dhellemmes, Elodie Denis, Emeline Mundwiller, Arnaud Lacour, Didier Ferriby, Bruno Georges Sautière, David Devos, Giovanni Stevanin, Bernard Puech, Patrick Vermersch
Publikováno v:
Ophthalmology. 118:564-573
Objective Kjellin's syndrome is a hereditary neuro-ophthalmologic syndrome. We describe the clinical phenotypes of 7 patients, identifying the responsible mutations for 4 of them. A 10-year ophthalmologic and neurologic follow-up of 5 patients allowe
Publikováno v:
La Revue de Médecine Interne. 31:S8-S15
PURPOSE To describe clinical and physiopathological aspects of neurological involvement in neurological Sjogren syndrome (SS) and to overview biological markers and therapeutical aspects. CURRENT KNOWLEDGE AND KEY POINTS Neurological complications du
Autor:
Didier Ferriby, F. Blanc, Fabrice Berna, J. de Seze, Elisabeth Ruppert, Pierre Vidailhet, Marie-Céline Fleury, L. Lita, Patrick Vermersch
Publikováno v:
Revue Neurologique. 166:39-48
Resume Introduction L’existence de troubles psychotiques dans la sclerose en plaques (SEP), en particulier, revelatrice de la maladie, est mal connue. Methode Nous rapportons les caracteristiques neurologiques, psychiatriques, les donnees IRM, l’
Autor:
Tanya Stojkovic, M. Cabaret, Kathy Dujardin, J. de Seze, G. Dubois, Didier Ferriby, Hélène Zéphir, Patrick Vermersch, S. Bouillaguet
Publikováno v:
Revue Neurologique. 164:47-52
Interferons beta have shown some positive effects on cognitive function in multiple sclerosis (MS). The potential immunosuppressive impact of mitoxantrone on cognitive dysfunction in MS has never been evaluated. We assessed changes in cognitive dysfu
Autor:
E. Hachulla, J. de Seze, Patrick Vermersch, C. Crinquette, Didier Ferriby, S. Delalande, David Launay, T. Stojkovic, Claude-Alain Maurage
Publikováno v:
Revue Neurologique. 163:1075-1081
Resume Introduction L’atteinte d’un nerf crânien au cours d’une polymyosite a ete exceptionnellement rapportee. Observations Nous decrivons trois cas de polymyosite avec atteinte trigeminale ou faciale. Les patients presentaient un deficit mot
Autor:
T. Stojkovic, Luc Defebvre, Jean-Yves Gauvrit, M A Mackowiak, Patrick Vermersch, J. de Seze, S. Delalande, E. Michelin, Didier Ferriby, J P Pruvo
Publikováno v:
ResearcherID
Multiple sclerosis (MS) with clinical onset after 50 years of age is unusual (between 1 and 6%) and is frequently misdiagnosed. Furthermore, brain magnetic resonance imaging (MRI) abnormalities are frequently observed in subjects over 50 years of age
Publikováno v:
Revue Neurologique. 160:1207-1210
Resume Introduction Le syndrome de Guillain-Barre (SGB) se caracterise par une atteinte du systeme nerveux peripherique habituellement exclusive. Cependant, des cas associes a une encephalopathie ont ete decrits. Observations Dans ce travail, nous de
Autor:
T. Stojkovic, C. Ramirez, Didier Ferriby, Alain Destée, A. Al Khedr, Patrick Vermersch, E. Michelin, J. de Seze, S. Delalande
Publikováno v:
Revue Neurologique. 160:1048-1058
Resume Introduction La preuve biologique d’une atteinte infectieuse dans les myelopathies aigues est difficile a confirmer car il s’agit parfois d’une atteinte post-infectieuse. Objectifs L’objectif de cette etude a ete de definir le profil c
Autor:
Didier Ferriby, Jérôme De Seze, Sylvain Dubucquoi, Anne-Laure Fauchais, Tanya Stojkovic, Eric Hachulla, Pierre-Yves Hatron, Jean-Pierre Pruvo, S. Delalande, Patrick Vermersch
Publikováno v:
Medicine. 83:280-291
Neurologic involvement occurs in approximately 20% of patients with primary Sjogren syndrome (SS). However, the diagnosis of SS with neurologic involvement is sometimes difficult, and central nervous system (CNS) manifestations have been described ra